Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D R Stewart

Showing results (71-80 of 79) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 79 results.
American Journal of Industrial Medicine|December 1, 1995
Laboratory methods for evaluating early pregnancy loss in an industry-based populationB L Lasley, P Lohstroh, A Kuo, et al.
Die Pharmazie|October 31, 2006
Pharmaceutical development, quality control, stability and compatibility of a parenteral lyophilized formulation of the investigational polymer-conjugated platinum antineoplastic agent AP5346S C Van der Schoot, B Nuijen, P Sood, et al.
Clinical Endocrinology|April 1, 1993
The relationship between hCG and relaxin secretion in normal pregnancies vs peri-implantation spontaneous abortionsD R Stewart, J W Overstreet, A C Celniker, et al.
Anti-Cancer Drugs|October 24, 2002
Stability and compatibility of the investigational polymer-conjugated platinum anticancer agent AP 5280 in infusion systems and its hemolytic potentialM Bouma, B Nuijen, D R Stewart, et al.
The Journal of Clinical Endocrinology and Metabolism|March 1, 1997
The role of relaxin in glycodelin secretionD R Stewart, M S Erikson, M E Erikson, et al.
Andrology|October 11, 2014
Familial testicular germ cell tumors (FTGCT) - overview of a multidisciplinary etiologic studyM H Greene, P L Mai, J T Loud, et al.
The Journal of Clinical Endocrinology and Metabolism|July 27, 2006
Fine mapping of genetic susceptibility to polycystic ovary syndrome on chromosome 19p13.2 and tests for regulatory activityD R Stewart, B A Dombroski, M Urbanek, et al.
Drug Development and Industrial Pharmacy|November 11, 2003
Pharmaceutical development of a parenteral lyophilized formulation of the investigational polymer-conjugated platinum anticancer agent AP 5280M Bouma, B Nuijen, R Harms, et al.
Oncogene|January 10, 2017
The primacy of NF1 loss as the driver of tumorigenesis in neurofibromatosis type 1-associated plexiform neurofibromasA Pemov, H Li, R Patidar, et al.
Pageof 8

Showing results (71-80 of 79) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 79 results.
American Journal of Industrial Medicine|December 1, 1995
Laboratory methods for evaluating early pregnancy loss in an industry-based populationB L Lasley, P Lohstroh, A Kuo, et al.
Die Pharmazie|October 31, 2006
Pharmaceutical development, quality control, stability and compatibility of a parenteral lyophilized formulation of the investigational polymer-conjugated platinum antineoplastic agent AP5346S C Van der Schoot, B Nuijen, P Sood, et al.
Clinical Endocrinology|April 1, 1993
The relationship between hCG and relaxin secretion in normal pregnancies vs peri-implantation spontaneous abortionsD R Stewart, J W Overstreet, A C Celniker, et al.
Anti-Cancer Drugs|October 24, 2002
Stability and compatibility of the investigational polymer-conjugated platinum anticancer agent AP 5280 in infusion systems and its hemolytic potentialM Bouma, B Nuijen, D R Stewart, et al.
The Journal of Clinical Endocrinology and Metabolism|March 1, 1997
The role of relaxin in glycodelin secretionD R Stewart, M S Erikson, M E Erikson, et al.
Andrology|October 11, 2014
Familial testicular germ cell tumors (FTGCT) - overview of a multidisciplinary etiologic studyM H Greene, P L Mai, J T Loud, et al.
The Journal of Clinical Endocrinology and Metabolism|July 27, 2006
Fine mapping of genetic susceptibility to polycystic ovary syndrome on chromosome 19p13.2 and tests for regulatory activityD R Stewart, B A Dombroski, M Urbanek, et al.
Drug Development and Industrial Pharmacy|November 11, 2003
Pharmaceutical development of a parenteral lyophilized formulation of the investigational polymer-conjugated platinum anticancer agent AP 5280M Bouma, B Nuijen, R Harms, et al.
Oncogene|January 10, 2017
The primacy of NF1 loss as the driver of tumorigenesis in neurofibromatosis type 1-associated plexiform neurofibromasA Pemov, H Li, R Patidar, et al.
Pageof 8